Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

New respiratory symptoms and lung imaging findings in a woman with polymyositis.

Bolaki M, Karagiannis K, Bertsias G, Mitrouska I, Tzanakis N, Antoniou KM.

Breathe (Sheff). 2018 Jun;14(2):e34-e39. doi: 10.1183/20734735.000118.

2.

Clinical applications of mesenchymal stem cells in chronic lung diseases.

Antoniou KM, Karagiannis K, Tsitoura E, Bibaki E, Lasithiotaki I, Proklou A, Spandidos DA, Tzanakis N.

Biomed Rep. 2018 Apr;8(4):314-318. doi: 10.3892/br.2018.1067. Epub 2018 Feb 16.

3.

Evolution of echovirus 11 in a chronically infected immunodeficient patient.

Laassri M, Zagorodnyaya T, Hassin-Baer S, Handsher R, Sofer D, Weil M, Karagiannis K, Simonyan V, Chumakov K, Shulman L.

PLoS Pathog. 2018 Mar 19;14(3):e1006943. doi: 10.1371/journal.ppat.1006943. eCollection 2018 Mar.

4.

Separation and assembly of deep sequencing data into discrete sub-population genomes.

Karagiannis K, Simonyan V, Chumakov K, Mazumder R.

Nucleic Acids Res. 2017 Nov 2;45(19):10989-11003. doi: 10.1093/nar/gkx755.

5.

Impaired mRNA Expression of the Migration Related Chemokine Receptor CXCR4 in Mesenchymal Stem Cells of COPD Patients.

Karagiannis K, Proklou A, Tsitoura E, Lasithiotaki I, Kalpadaki C, Moraitaki D, Sperelakis I, Kontakis G, Antoniou KM, Tzanakis N.

Int J Inflam. 2017;2017:6089425. doi: 10.1155/2017/6089425. Epub 2017 Jul 19.

6.

Mesenchymal stem cell treatment for IPF-time for phase 2 trials?

Antoniou KM, Karagiannis K, Tsitoura E, Tzanakis N.

Lancet Respir Med. 2017 Jun;5(6):472-473. doi: 10.1016/S2213-2600(17)30180-7. Epub 2017 May 26. Review. No abstract available.

PMID:
28664848
7.

HIVE-heptagon: A sensible variant-calling algorithm with post-alignment quality controls.

Simonyan V, Chumakov K, Donaldson E, Karagiannis K, Lam PV, Dingerdissen H, Voskanian A.

Genomics. 2017 Jul;109(3-4):131-140. doi: 10.1016/j.ygeno.2017.01.002. Epub 2017 Feb 8.

PMID:
28188908
8.

MiR-185/AKT and miR-29a/collagen 1a pathways are activated in IPF BAL cells.

Tsitoura E, Wells AU, Karagiannis K, Lasithiotaki I, Vasarmidi E, Bibaki E, Koutoulaki C, Sato H, Spandidos DA, Siafakas NM, Sourvinos G, Antoniou KM.

Oncotarget. 2016 Nov 15;7(46):74569-74581. doi: 10.18632/oncotarget.12740.

9.

Evidence that a polyhexameric genome length is preferred, but not strictly required, for efficient mumps virus replication.

Sauder CJ, Simonyan V, Ngo L, Karagiannis K, Cong Y, Zhang C, Wang R, Wu WW, Malik T, Rubin SA.

Virology. 2016 Jun;493:173-88. doi: 10.1016/j.virol.2016.03.021. Epub 2016 Apr 6.

10.

High-performance integrated virtual environment (HIVE): a robust infrastructure for next-generation sequence data analysis.

Simonyan V, Chumakov K, Dingerdissen H, Faison W, Goldweber S, Golikov A, Gulzar N, Karagiannis K, Vinh Nguyen Lam P, Maudru T, Muravitskaja O, Osipova E, Pan Y, Pschenichnov A, Rostovtsev A, Santana-Quintero L, Smith K, Thompson EE, Tkachenko V, Torcivia-Rodriguez J, Voskanian A, Wan Q, Wang J, Wu TJ, Wilson C, Mazumder R.

Database (Oxford). 2016 Mar 17;2016. pii: baw022. doi: 10.1093/database/baw022. Print 2016.

11.

Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension.

Antoniou KM, Margaritopoulos GA, Goh NS, Karagiannis K, Desai SR, Nicholson AG, Siafakas NM, Coghlan JG, Denton CP, Hansell DM, Wells AU.

Arthritis Rheumatol. 2016 Apr;68(4):1004-12. doi: 10.1002/art.39528.

12.

Human germline and pan-cancer variomes and their distinct functional profiles.

Pan Y, Karagiannis K, Zhang H, Dingerdissen H, Shamsaddini A, Wan Q, Simonyan V, Mazumder R.

Nucleic Acids Res. 2014 Oct;42(18):11570-88. doi: 10.1093/nar/gku772. Epub 2014 Sep 17.

13.

Treatment strategies for idiopathic interstitial pneumonias.

Wells AU, Kokosi M, Karagiannis K.

Curr Opin Pulm Med. 2014 Sep;20(5):442-8. doi: 10.1097/MCP.0000000000000085. Review.

PMID:
25032814
14.

Non-synonymous variations in cancer and their effects on the human proteome: workflow for NGS data biocuration and proteome-wide analysis of TCGA data.

Cole C, Krampis K, Karagiannis K, Almeida JS, Faison WJ, Motwani M, Wan Q, Golikov A, Pan Y, Simonyan V, Mazumder R.

BMC Bioinformatics. 2014 Jan 27;15:28. doi: 10.1186/1471-2105-15-28.

15.

Deep sequencing approach for genetic stability evaluation of influenza A viruses.

Bidzhieva B, Zagorodnyaya T, Karagiannis K, Simonyan V, Laassri M, Chumakov K.

J Virol Methods. 2014 Apr;199:68-75. doi: 10.1016/j.jviromet.2013.12.018. Epub 2014 Jan 7.

PMID:
24406624
16.

SNVDis: a proteome-wide analysis service for evaluating nsSNVs in protein functional sites and pathways.

Karagiannis K, Simonyan V, Mazumder R.

Genomics Proteomics Bioinformatics. 2013 Apr;11(2):122-6. doi: 10.1016/j.gpb.2012.10.003. Epub 2012 Dec 5.

17.

Structure-based comparative analysis and prediction of N-linked glycosylation sites in evolutionarily distant eukaryotes.

Lam PV, Goldman R, Karagiannis K, Narsule T, Simonyan V, Soika V, Mazumder R.

Genomics Proteomics Bioinformatics. 2013 Apr;11(2):96-104. doi: 10.1016/j.gpb.2012.11.003. Epub 2013 Feb 28.

18.

Proteome-wide analysis of nonsynonymous single-nucleotide variations in active sites of human proteins.

Dingerdissen H, Motwani M, Karagiannis K, Simonyan V, Mazumder R.

FEBS J. 2013 Mar;280(6):1542-62. doi: 10.1111/febs.12155. Epub 2013 Feb 24.

19.

Investigation of Telomerase/Telomeres system in Bone Marrow Mesenchymal Stem Cells derived from IPF and RA-UIP.

Antoniou KM, Margaritopoulos GA, Proklou A, Karagiannis K, Lasithiotaki I, Soufla G, Kastrinaki MC, Spandidos DA, Papadaki HA, Siafakas NM.

J Inflamm (Lond). 2012 Jul 2;9(1):27. doi: 10.1186/1476-9255-9-27.

20.

Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ).

Tsiligianni IG, van der Molen T, Moraitaki D, Lopez I, Kocks JW, Karagiannis K, Siafakas N, Tzanakis N.

BMC Pulm Med. 2012 May 20;12:20. doi: 10.1186/1471-2466-12-20.

21.

Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis.

Samara KD, Antoniou KM, Karagiannis K, Margaritopoulos G, Lasithiotaki I, Koutala E, Siafakas NM.

Int J Oncol. 2012 May;40(5):1397-404. doi: 10.3892/ijo.2012.1374. Epub 2012 Feb 15.

PMID:
22344343
22.

Detection of herpes simplex virus type-1 in patients with fibrotic lung diseases.

Lasithiotaki I, Antoniou KM, Vlahava VM, Karagiannis K, Spandidos DA, Siafakas NM, Sourvinos G.

PLoS One. 2011;6(12):e27800. doi: 10.1371/journal.pone.0027800. Epub 2011 Dec 20.

23.

Isolated right diaphragmatic rupture following blunt trauma.

Baloyiannis I, Kouritas VK, Karagiannis K, Spyridakis M, Efthimiou M.

Gen Thorac Cardiovasc Surg. 2011 Nov;59(11):760-2. doi: 10.1007/s11748-010-0759-8. Epub 2011 Nov 15.

PMID:
22083696
24.

Investigation of angiogenetic axis Angiopoietin-1 and -2/Tie-2 in fibrotic lung diseases: a bronchoalveolar lavage study.

Margaritopoulos GA, Antoniou KM, Karagiannis K, Vassalou E, Lasithiotaki I, Lambiri I, Siafakas NM.

Int J Mol Med. 2010 Dec;26(6):919-23.

PMID:
21042788
25.

Investigation of Toll-like receptors in the pathogenesis of fibrotic and granulomatous disorders: a bronchoalveolar lavage study.

Margaritopoulos GA, Antoniou KM, Karagiannis K, Samara KD, Lasithiotaki I, Vassalou E, Lymbouridou R, Koutala H, Siafakas NM.

Fibrogenesis Tissue Repair. 2010 Oct 11;3:20. doi: 10.1186/1755-1536-3-20.

26.

Role of VEGF-stromal cell-derived factor-1alpha/CXCL12 axis in pleural effusion of lung cancer.

Economidou F, Antoniou KM, Soufla G, Lasithiotaki I, Karagiannis K, Lymbouridou R, Proklou A, Spandidos DA, Siafakas NM.

J Recept Signal Transduct Res. 2010 Jun;30(3):154-60. doi: 10.3109/10799891003671147.

PMID:
20196627
27.

Upregulation of stromal cell derived factor-1alpha in collagen vascular diseases-associated interstitial pneumonias (CVDs-IPs).

Margaritopoulos GA, Antoniou KM, Soufla G, Karagiannis K, Proklou A, Lasithiotaki I, Tzanakis N, Spandidos DA, Siafakas NM.

Pulm Pharmacol Ther. 2010 Apr;23(2):115-20. doi: 10.1016/j.pupt.2009.10.008. Epub 2009 Oct 28.

PMID:
19878731
28.

Increased bronchoalveolar lavage fluid CD1c expressing dendritic cells in idiopathic pulmonary fibrosis.

Tsoumakidou M, Karagiannis KP, Bouloukaki I, Zakynthinos S, Tzanakis N, Siafakas NM.

Respiration. 2009;78(4):446-52. doi: 10.1159/000226244. Epub 2009 Jun 24.

PMID:
19556741
29.

Semen collection and artificial insemination in the common piping guan (Pipile cumanensis cumanensis): potential applications for Cracidae (Aves: Galliformes).

DeMatteo KE, Karagiannis KL, Asa CS, Macek MS, Snyder TL, Tieber AM, Parker PG.

J Zoo Wildl Med. 2004 Dec;35(4):447-58.

PMID:
15732585
30.

Synthesis of potent agonists of substance P by replacement of Met11 with Glu(OBzl) and N-terminal glutamine with Glp of the C-terminal hexapeptide and heptapeptide of substance P.

Stavropoulos G, Karagiannis K, Anagnostides S, Ministrouski I, Selinger Z, Chorev M.

Int J Pept Protein Res. 1995 Jun;45(6):508-13.

PMID:
7558580
31.

Synthesis and biological activity of locust AKH-I and its analogues with modifications at the threonine residues.

Poulos C, Karagiannis K, Lee M, Goldsworthy G.

Int J Pept Protein Res. 1994 Dec;44(6):589-93.

PMID:
7705981
32.

Synthesis of a potent antagonist of substance P by replacing the CH2SCH3 and the alpha-carboxamide groups of the methionine at [Orn6]-SP6-11 by benzyl ester groups.

Karagiannis K, Stavropoulos G, Poulos C, Jordan CC, Hagan RM.

Int J Pept Protein Res. 1993 Dec;42(6):565-9.

PMID:
7508424
33.

Synthesis of potent antagonists of substance P by modifying the methionyl and glutaminyl residues of its C-terminal hexapeptide and without using D-amino acids.

Manolopoulou A, Karagiannis K, Stavropoulos G, Poulos C, Jordan CC, Hagan RM.

Int J Pept Protein Res. 1993 Apr;41(4):411-4.

PMID:
7684361
34.

Solid-phase synthesis and spectroscopic studies of TRH analogues incorporating cis- and trans-4-hydroxy-L-proline.

Stavropoulos G, Karagiannis K, Vynios D, Papaloannou D, Aksnes DW, Age Fr√łystein N, Francis GW.

Acta Chem Scand. 1991 Nov;45(10):1047-54.

PMID:
1768533
35.

Synthesis of a potent agonist of substance P by modifying the methionyl and glutaminyl residues of the C-terminal hexapeptide of substance P. Structure-activity relationships.

Karagiannis K, Manolopoulou A, Stavropoulos G, Poulos C, Jordan CC, Hagan RM.

Int J Pept Protein Res. 1991 Oct;38(4):350-6.

PMID:
1724664
36.

Synthesis and biological activity of substance P C-terminal hexapeptide and heptapeptide analogues.

Stavropoulos G, Karagiannis K, Cordopatis P, Halle D, Gilon C, Bar-Akiva G, Selinger Z, Chorev M.

Int J Pept Protein Res. 1991 Mar;37(3):180-4.

PMID:
1714423

Supplemental Content

Loading ...
Support Center